Fasikl
MN - MinneapolisBiotechnology
Focus: Fasikl develops a needle-based device for ultrasound-guided transection of soft tissue adhesions, operating as an early-stage medical device biotech in Minneapolis. The company appears to be in pre-commercial or early developmental stages with minimal disclosed operations.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Fasikl
AI assessmentNot HiringNo open roles listed right now. Follow Fasikl to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Felix NeuroAI Wristband
Essential TremorClinical Trials (1)
NCT06235190Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor
N/AHelp build intelligence for Fasikl
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.